Genetic and molecular factors in myocardial fibrosis

Bidragets beskrivning

Cardiovascular diseases are globally among the leading causes of mortality. Myocardial fibrosis means accumulation of excess of extracellular matrix in the heart. After myocardial infarction cardiomyocytes die and fibrotic scar is formed to protect the integrity of the heart. Accumulation of excess of fibrotic tissue can also be a response to for example ageing or obesity. Fibrosis increases cardiac tissue stiffness leading to impaired heart function and predisposes to sudden cardiac death. In this research, I will identify new genetic factors leading to myocardial fibrosis and sudden cardiac death in a unique data set of 228 sudden cardiac death victims. I will also investigate the role of miRNA editing, a regulatory mechanism for gene expression, in cardiac fibrosis using patient samples and cell models. Furthermore, I investigate if diagnosis of fibrosis and prediction of sudden cardiac death could be improved by using miRNAs as biomarkers.
Visa mer

Startår

2022

Slutår

2026

Beviljade finansiering

Sini Skarp Orcid -palvelun logo
245 296 €

Finansiär

Finlands Akademi

Typ av finansiering

Forskardoktorer

Utlysning

Beslutfattare

Forskningsrådet för biovetenskap, hälsa och miljö
28.04.2022

Övriga uppgifter

Finansieringsbeslutets nummer

349331

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet

Identifierade teman

cardiovascular diseases